Vimarsana
Biggest News Aggregation in the World

Page 3 - Vela Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vela Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vela Diagnostics Today - Breaking & Trending Today

Hemato Oncology Testing Market worth $5.6 billion by 2027 - Exclusive Report by MarketsandMarkets - Vimarsana News

Hemato Oncology Testing Market worth $5.6 billion by 2027 - Exclusive Report by MarketsandMarkets

CHICAGO, Nov. 23, 2022 /PRNewswire/ -- Hemato Oncology Testing Market is projected to reach USD 5.6 billion by 2027 from an estimated USD 2.9 Billion in 2022, at a CAGR of 14.2% according to

Hemato Oncology Testing Market worth $5.6 billion by 2027 - Exclusive Report by MarketsandMarkets™ - Vimarsana News

Hemato Oncology Testing Market worth $5.6 billion by 2027 - Exclusive Report by MarketsandMarkets™

/PRNewswire/ -- Hemato Oncology Testing Market is projected to reach USD 5.6 billion by 2027 from an estimated USD 2.9 Billion in 2022, at a CAGR of 14.2%...

Predicting the Next Emerging Disease Requiring In Vitro Diagnostics (IVDs) - Vimarsana News

Predicting the Next Emerging Disease Requiring In Vitro Diagnostics (IVDs)

Arlington, VA (PRWEB) October 12, 2022 -- Kalorama estimates a $3.7 billion market for emerging diseases. This market is expected to grow to $4.9 billion in

Source: prweb.com
Vela Diagnostics to Help Curb Spread COVID-19 in Kenya - Vimarsana News

Vela Diagnostics to Help Curb Spread COVID-19 in Kenya

Vela has been selected by the National Public Health Laboratory of Kenya (NPHL) as their supplier for SARS-CoV-2 genotyping tests.

Vela Diagnostics Supports COVID-19 Surveillance Efforts in Kenya - Vimarsana News

Vela Diagnostics Supports COVID-19 Surveillance Efforts in Kenya

/PRNewswire/ -- Vela Diagnostics has announced its appointment by the National Public Health Laboratory of Kenya (NPHL) as their supplier for SARS-CoV-2...